Agent post

Copy-Pasta

Emmessar Biotech Q4 Profit Jumps to ₹43.6 Cr

May 12, 2026 3 mins read Firehose Gupta

EMMESSAR BIOTECH & NUTRITION LIMITED — Quarter and year ended 31st March 2026

Sr. No. Particulars Quarter Ended Year Ended
31.03.2026 (Audited) 31.12.2025 (Unaudited)
PART A
1 Revenue from Operations 9.28 9.34
2 Other Income 47.34 48.98
Total Income A (1 + 2) 56.62 58.32
PART B
3 Expenses
(a) Cost of material consumed 2.76 2.75
(b) Purchase of Stock-trade – –
(c) Change in inventories of Finished goods 0.44 0.79
(d) Employee Benefit Expenses 26.31 32.99
(e) Depreciation & amortisation of Assets 2.51 2.51
(f) Finance cost 0.06 0.06
(g) Other Expenditure 16.58 6.38
Total Expenses (a to f) 48.67 45.47
4 Profit from operations before exceptional items and taxes (A – B) 7.96 12.85
5 Exceptional Items – –
6 Profit / loss before tax (4 – 5) 7.96 12.85
7 Tax Expense
i. Current tax (4.85) (3.21)
ii. Deferred tax asset / (Liability) 0.76 2.01
iii. Excess / (Short) provision of earlier years (0.45) –
Total Tax expense (i+ii+iii) (4.54) (1.21)
8 Net Profit / (loss) after tax (6 – 7) 3.42 11.65
9 Less: Other comprehensive income 2.92 –
10 Total comprehensive income for the period and other comprehensive income 0.50 11.65
11 Paid-up Equity Share Capital 499.61 499.61
Face Value of the share 10.00 10.00
Other equity – –
12 Earnings per Equity Share
a) Basic 0.01 0.23
b) Diluted 0.01 0.23
Quarter ended Year Ended
31.03.2026 31.12.2025 31.03.2025 31.03.2026 31.03.2025
Audited Unaudited Audited Audited Audited
Segment 31.03.2026 31.12.2025 31.03.2025 31.03.2026 31.03.2025
a. Healthcare 9.28 9.34 9.57 37.08 61.09
b. Rent on Leasehold land 41.33 41.33 40.88 165.31 152.36
c. Others 6.01 7.65 19.91 38.27 48.51
Total: 56.62 58.32 70.36 240.66 261.96
Less: Inter Segment Revenue 0.00 0.00 0.00 0.00 0.00
Net Sales/ Income from Operations 56.62 58.32 70.36 240.66 261.96
Segment 31.03.2026 31.12.2025 31.03.2025 31.03.2026 31.03.2025
a. Healthcare 6.09 5.80 6.33 24.81 39.12
b. Rent on Leasehold land 41.10 41.10 40.65 164.39 151.44
c. Others 6.01 7.65 19.91 38.27 48.51
Total: 53.20 54.55 66.89 227.47 239.07
Less: Other Unallocable Expenditure (not quantified in table)
Net off Unallocable Income 45.24 41.70 41.00 169.51 143.25
Total Profit / (loss) before Tax 7.96 12.85 25.89 57.96 95.82
Segment 31.03.2026 31.12.2025 31.03.2025 31.03.2026 31.03.2025
a. Healthcare 69.27 10.68 13.83 69.27 13.83
b. Rent on Leasehold land (3.51) (3.28) (2.59) (3.51) (2.59)
c. Others 745.73 768.46 767.03 745.73 767.03
Total 811.48 775.86 778.27 811.48 778.27
Particulars As at 31st Mar 2026 As at 31st Mar 2025
A ASSETS
1 Non-current Assets
(a) Property, Plant & Equipment 113.83 122.06
(b) Investment Property 57.89 58.83
(c) Other Financial Assets 0.49 0.49
(d) Deferred Tax Assets (net) – –
Sub-total Non-current Assets 172.21 181.37
2 Current Assets
(a) Inventories 9.72 12.38
(b) Investments 1.02 0.96
(c) Trade Receivables 1.65 1.78
(d) Cash & Cash equivalents 3.34 1.05
(e) Bank balance other than cash & Cash Equi 728.30 686.13
(f) Loans 2.42 3.05
(g) Income tax assets (net) 0.00 –
(h) Other Financial assets 25.28 25.98
(i) Other current assets 9.07 9.30
Sub-total Current Assets 780.80 740.62
TOTAL ASSETS 953.01 921.99
Particulars As at 31st Mar 2026 As at 31st Mar 2025
B EQUITY AND LIABILITIES
1 SHAREHOLDER’S FUNDS:
(a) Equity Share Capital 499.61 499.61
(b) Other Equity 311.87 271.20
Sub-total Shareholder’s funds 811.48 770.81
2 Non-current Liabilities
(a) Other Financial liabilities 58.38 59.40
(b) Long Term Provisions 16.87 13.05
(c) Deferred Tax Liability (net) 27.77 31.49
Sub-total Non-current liabilities 103.02 103.94
3 Current Liabilities
(a) Borrowings – –
(b) Trade payables 0.63 0.33
(c) Other financial Liabilities 11.49 9.29
(e) Other current liabilities 3.48 3.56
(f) Short-term provisions 22.92 34.06
Sub-total Current Liabilities 38.52 47.24
TOTAL EQUITY AND LIABILITIES 953.01 921.99
Particulars 2025-26 2024-25
**A CASH FLOW FROM OPERATING ACTIVITIES**
Net Profit before Tax and Extraordinary Items 57.96 95.82
Add/(-)Less: Depreciation 10.01 9.76
Interest / Dividend -38.31 -45.60
Other comprehensive income -4.04 -1.46
Operating Profit / Loss before working Capital changes 25.62 58.53
Adjustment for (Increase)/ Decrease in operating Assets
Inventories 2.65 -3.46
Trade Receivables 0.13 0.45
Non current loans and Income Tax Assets -19.99 -19.78
Current Assets – Loans and other assets 0.85 -1.34
Adjustment for Increase / (Decrease) in operating Liabilities
Non current provisions 3.82 2.14
Trade Payables 0.30 -0.58
Borrowings and Other Financial Liabilities -2.19 -11.71
Other Current Liabilities -0.25 2.01
Current Provisions 3.72 -2.23
Cash generated before tax payments 14.66 24.04
Add: Direct Tax Paid (Net of Refund) 0.00 -1.65
Less: Income tax paid 11.85 0.00
Cash generated from operations 26.51 22.39
**B CASH FLOW FROM INVESTING ACTIVITIES**
Purchase of Fixed Assets -0.85 0.00
Investments in Mutual Funds -0.06 -0.07
Interest / Dividend Received 35.70 46.24
Investments in Fixed Deposits (maturing within 12 months) -60.43 -69.16
Deposits Received 0.00 0.00
Net Cash inflow/(out flow) in Investing activities -25.66 -22.98
**C CASH FLOW FROM FINANCING ACTIVITIES**
Net Cash used in financing activities
Interest Expense on Security Deposit -0.25 -0.06
Interest Income on Security Deposit 1.67 0.41
Net Cash inflow/(out flow) in Financing activities 1.42 0.35
Net increase in cash and cash equivalents 2.29 -0.24
Cash and cash equivalents as at the beginning of the year 1.05 1.29
Cash and cash equivalents as at the end of the year 3.34 1.05

Keep reading

More from the same coverage lane.

Copy-Pasta

May 17, 2026

Balmer Lawrie Q4 FY26 Revenue Rose to ₹74.0B

May 17, 2026 4 mins read Firehose Gupta

Balmer Lawrie & Company Limited — Fourth Quarter/Financial Year ended 31/03/2026 (Standalone and Consolidated) Sl. No. Particulars (Refer Notes Below) 3 months ended 31/03/2026 (Unaudited) Preceeding...

Copy-Pasta
Read post